Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.
暂无分享,去创建一个
Seth Love | Jason Berwick | Jozien Goense | Tao Wang | Maiken Nedergaard | Hugh S Markus | Joanna M Wardlaw | Adam Harvey | Lisa M Saksida | M. Z. Cader | Anne Joutel | Rikesh M. Rajani | Philip M Bath | Patrick G Kehoe | L. Saksida | Steven C. R. Williams | J. Goense | J. Berwick | S. Love | P. Kehoe | R. Carare | M. Nedergaard | M. Macleod | B. McColl | J. Wardlaw | Colin Smith | R. Touyz | H. Markus | R. Kalaria | Kenneth J. Smith | T. Quinn | A. Hainsworth | A. Harvey | S. Allan | P. Bath | J. Duncombe | L. Work | A. Joutel | T. Farr | J. Fowler | Catherine Hall | K. Horsburgh | C. Lawrence | R. Trueman | C. McCabe | Anna C. Williams | Rosalind Brown | I. Macrae | Malcolm R Macleod | John B Davis | Rhian M Touyz | Cheryl A Hawkes | Malcolm R Macleod | Steven C R Williams | Anna Williams | C. Hawkes | P. Meakin | Barry W McColl | Kenneth J Smith | Stuart M Allan | Colin Smith | M Zameel Cader | Terry J Quinn | Paul J Meakin | Roxana O Carare | Rajesh N Kalaria | I Mhairi Macrae | Alessandra Granata | Lorraine M Work | Catherine B Lawrence | Karen Horsburgh | Atticus H Hainsworth | Tom van Agtmael | Mike L J Ashford | Rosalind Brown | Jessica Duncombe | Tracy D Farr | Jill H Fowler | Catherine N Hall | Andy Lockhart | Chris McCabe | Alyson Miller | Michael O'Sullivan | Rikesh Rajani | Rebecca C Trueman | M. Ashford | T. Van Agtmael | John B. Davis | A. Granata | Tao Wang | Tao Wang | Alyson A Miller | H. Markus | Michael J. O’Sullivan | S. Williams | Andy Lockhart | Jill H. Fowler | Tom Van Agtmael | Joanna M. Wardlaw | Jill H. Fowler | Karen Horsburgh | Tracy D. Farr | Patrick G. Kehoe | Malcolm R Macleod | I. Macrae | Steven C.R. Williams | M. Cader | Joanna M. Wardlaw | Stuart M. Allan | Mike L.J. Ashford | P. M. Bath | John B. Davis | Catherine N. Hall | Cheryl Hawkes | Rajesh N. Kalaria | Catherine B. Lawrence | Andy Lockhart | Seth Love | Malcolm R. Macleod | Hugh S. Markus | Christopher Mccabe | Michael O'Sullivan | Terry J Quinn | Colin Smith | Kenneth J. Smith | Anna Williams | Cheryl A Hawkes | R. Kalaria | Steven C.R. Williams | Adam P. Harvey
[1] I. Cuthill,et al. Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .
[2] H. Markus,et al. Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] Ian Marshall,et al. Cerebral blood flow in small vessel disease: A systematic review and meta-analysis , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[5] K. Fujihara,et al. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination , 2010, Acta Neuropathologica.
[6] C. Iadecola,et al. The Pathobiology of Vascular Dementia , 2013, Neuron.
[7] N. Plesnila,et al. Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , 2015, Annals of neurology.
[8] A M Owen,et al. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. , 1992, Journal of the Royal Society of Medicine.
[9] C. Sobey,et al. Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation , 2014, Journal of hypertension.
[10] D. Borchelt,et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.
[11] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[12] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[13] G. Biessels. Diagnosis and treatment of vascular damage in dementia. , 2016, Biochimica et biophysica acta.
[14] C. Sudlow,et al. Etiology of Stroke and Choice of Models , 2012, International journal of stroke : official journal of the International Stroke Society.
[15] D. Werring,et al. Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling , 2014, Proceedings of the National Academy of Sciences.
[16] R. Kalaria,et al. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. , 2017, Clinical science.
[17] Jan Warnking,et al. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI , 2011, NeuroImage.
[18] M. Dichgans,et al. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. , 2015, Brain : a journal of neurology.
[19] M. Fujishima,et al. Vascular changes underlying cerebral lesions in stroke-prone spontaneously hypertensive rats , 2004, Acta Neuropathologica.
[20] L. Wilkins. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL) , 2017, Neurology.
[21] C. Labelle-Dumais,et al. COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets , 2012, Human molecular genetics.
[22] M. Bastin,et al. Hypertension Fails to Disrupt White Matter Integrity in Young Or Aged Fisher (F44) Cyp1a1Ren2 Transgenic Rats , 2015, Journal of Cerebral Blood Flow and Metabolism.
[23] M. Ihara,et al. White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion , 2004, Stroke.
[24] Reinhold Schmidt,et al. Consensus statement for diagnosis of subcortical small vessel disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] M. Moss,et al. Translational models for vascular cognitive impairment: a review including larger species , 2017, BMC Medicine.
[26] Arvind Caprihan,et al. Long-Term Blood–Brain Barrier Permeability Changes in Binswanger Disease , 2015, Stroke.
[27] S. Dohgu,et al. Tumor necrosis factor-α-stimulated brain pericytes possess a unique cytokine and chemokine release profile and enhance microglial activation , 2014, Neuroscience Letters.
[28] Malcolm Macleod,et al. How can we improve the pre-clinical development of drugs for stroke? , 2007, Trends in Neurosciences.
[29] M. Esiri,et al. Neuropathological assessment of the lesions of significance in vascular dementia , 1997, Journal of neurology, neurosurgery, and psychiatry.
[30] M. Dichgans,et al. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.
[31] P. Sandercock,et al. Does Early Reperfusion of a Cerebral Infarct Influence Cerebral Infarct Swelling in the Acute Stage or the Final Clinical Outcome , 1993 .
[32] Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. , 1999, Stroke.
[33] Daniel J. R. Christensen,et al. Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.
[34] W. Mcdonald,et al. Central remyelination restores secure conduction , 1979, Nature.
[35] K Broich,et al. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. , 2014, The journal of prevention of Alzheimer's disease.
[36] C. Maxwell,et al. Antihypertensive agents and prevention of dementia , 2010, BMJ : British Medical Journal.
[37] V. Hachinski. Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.
[38] H. Lassmann,et al. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.
[39] Joanna M. Wardlaw,et al. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial , 2015, The Lancet Neurology.
[40] Lisa M Saksida,et al. The touchscreen operant platform for testing working memory and pattern separation in rats and mice , 2013, Nature Protocols.
[41] C. Dufouil,et al. Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.
[42] R O Weller,et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.
[43] Junyang Jung,et al. Role of Gasotransmitters in Oxidative Stresses, Neuroinflammation, and Neuronal Repair , 2017, BioMed research international.
[44] Thorbjørn S. Engedal,et al. Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] Kristine Yaffe,et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.
[46] B. Zlokovic,et al. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.
[47] A. Akhmedov,et al. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. , 2017, American journal of physiology. Heart and circulatory physiology.
[48] A. Dominiczak,et al. An MRI-Histological Study of White Matter in Stroke-Free SHRSP , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] M. Macleod,et al. Emulating Multicentre Clinical Stroke Trials: A New Paradigm for Studying Novel Interventions in Experimental Models of Stroke , 2009, International journal of stroke : official journal of the International Stroke Society.
[50] Jeffrey L Saver,et al. The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.
[51] C. Sudlow,et al. Potential Animal Models of Lacunar Stroke: A Systematic Review , 2009, Stroke.
[52] J. Hendrikse,et al. Longitudinal Relationship Between Cerebral Small-Vessel Disease and Cerebral Blood Flow: The Second Manifestations of Arterial Disease-Magnetic Resonance Study , 2015, Stroke.
[53] L. Kuller,et al. Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults , 2013, Neurology.
[54] Sean P. Palecek,et al. Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.
[55] A. W. Chung,et al. Structural network efficiency is associated with cognitive impairment in small-vessel disease , 2014, Neurology.
[56] A. Planas,et al. Structural and functional brain alterations in a murine model of Angiotensin II‐induced hypertension , 2017, Journal of neurochemistry.
[57] Lisa J. Martin,et al. Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease , 2015, Neurology.
[58] Stephanie Schäfer,et al. What's Wrong With My Mouse?, J.N. Crawley. John Wiley and Sons Inc. (2000), Price: €92.00, ISBN: 0-471-31639-3 , 2007 .
[59] Mark Woodward,et al. Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke , 2016, Stroke.
[60] J. Searcy,et al. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice. , 2017, Clinical science.
[61] P. Rothwell,et al. Carotid Artery Imaging for Secondary Stroke Prevention: Both Imaging Modality and Rapid Access to Imaging Are Important , 2009, Stroke.
[62] Sean P. Palecek,et al. An isogenic blood–brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells , 2017, Journal of neurochemistry.
[63] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[64] V. Feigin,et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2014, The Lancet.
[65] C. Sudlow,et al. Pathology of Lacunar Ischemic Stroke in Humans—A Systematic Review , 2012, Brain pathology.
[66] Jian-Mei Li,et al. Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2 , 2014, British journal of clinical pharmacology.
[67] Nancy Argüelles,et al. Author ' s , 2008 .
[68] Shinya Yamanaka,et al. Induced pluripotent stem cell technology: a decade of progress , 2016, Nature Reviews Drug Discovery.
[69] C. Iadecola,et al. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. , 2011, American journal of physiology. Heart and circulatory physiology.
[70] V. Hachinski,et al. Declining Incidence of Stroke and Dementia: Coincidence or Prevention Opportunity? , 2015, JAMA neurology.
[71] V. Gudnason,et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study. , 2011, Brain : a journal of neurology.
[72] T. Kitazono,et al. Nox4 Is a Major Source of Superoxide Production in Human Brain Pericytes , 2014, Journal of Vascular Research.
[73] U. Dirnagl,et al. Neuroimaging Biomarkers Predict Brain Structural Connectivity Change in a Mouse Model of Vascular Cognitive Impairment , 2017, Stroke.
[74] G. Marchal,et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.
[75] N. Plesnila,et al. Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia , 2015, Science Translational Medicine.
[76] S. Pacini,et al. Commentary: Structural and functional features of central nervous system lymphatic vessels , 2015, Front. Neurosci..
[77] K. Fassbender,et al. Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. , 2014, Current Alzheimer research.
[78] D. Sosnowska,et al. Cardiovascular and Cerebrovascular Aging–New Mechanisms and Insights: Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase , 2014 .
[79] G. Mead,et al. Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia , 2013, Alzheimer's & Dementia.
[80] Joanna M. Wardlaw,et al. Genes From a Translational Analysis Support a Multifactorial Nature of White Matter Hyperintensities , 2015, Stroke.
[81] C. Ritchie,et al. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2017, The Cochrane database of systematic reviews.
[82] T. Robbins,et al. Assessing cognitive function in clinical trials of schizophrenia , 2010, Neuroscience & Biobehavioral Reviews.
[83] E. Wood,et al. Gliovascular Disruption and Cognitive Deficits in a Mouse Model with Features of Small Vessel Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[84] P. Katakam,et al. Role of Mitochondria in Cerebral Vascular Function: Energy Production, Cellular Protection, and Regulation of Vascular Tone. , 2016, Comprehensive Physiology.
[85] I. Deary,et al. Selective white matter pathology induces a specific impairment in spatial working memory , 2011, Neurobiology of Aging.
[86] David A. Bennett,et al. Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study , 2016, The Lancet Neurology.
[87] N. Plesnila,et al. Pericytes are involved in the pathogenesis of CADASIL , 2015 .
[88] Jürgen Hennig,et al. Ultra-fast magnetic resonance encephalography of physiological brain activity – Glymphatic pulsation mechanisms? , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[89] L. Saksida,et al. Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept) , 2011, The Journal of Neuroscience.
[90] M. Chopp,et al. White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies , 2017, Neurobiology of Aging.
[91] Xavier Golay,et al. Cause and prevention of demyelination in a model multiple sclerosis lesion , 2016, Annals of neurology.
[92] M. Nedergaard,et al. Garbage Truck of the Brain , 2013, Science.
[93] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[94] C. Sudlow,et al. Is the Spontaneously Hypertensive Stroke Prone Rat a Pertinent Model of Sub Cortical Ischemic Stroke? A Systematic Review , 2011, International journal of stroke : official journal of the International Stroke Society.
[95] D. Norris,et al. Nonlinear temporal dynamics of cerebral small vessel disease , 2017, Neurology.
[96] Alan D. Lopez,et al. Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.
[97] A. Joutel,et al. Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.
[98] M. Nelson,et al. Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain? , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[99] Michael Chopp,et al. Impairment of the glymphatic system after diabetes , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[100] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[101] Martin Dichgans,et al. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[102] Hilkka Soininen,et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.
[103] I. McKeith,et al. Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study , 2009, PLoS medicine.
[104] E. Rostrup,et al. Quantitative and qualitative MRI evaluation of cerebral small vessel disease in an elderly population: a longitudinal study , 2018, Acta radiologica.
[105] Michael Detmar,et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules , 2015 .
[106] Maiken Nedergaard,et al. Impairment of paravascular clearance pathways in the aging brain , 2014, Annals of neurology.
[107] C. Leffler,et al. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF‐alpha in cerebral vascular endothelial cells. , 2009, American journal of physiology. Cell physiology.
[108] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[109] J. Wardlaw,et al. Thrombectomy for Acute Ischemic Stroke. , 2015, JAMA.
[110] Lars Bäckman,et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.
[111] S. Ananiadou,et al. Risk of bias reporting in the recent animal focal cerebral ischaemia literature , 2017, Clinical science.
[112] Z. Katušić,et al. Endothelial nitric oxide: protector of a healthy mind. , 2014, European heart journal.
[113] M. Mesulam,et al. The Special Topics Section of Alzheimer's & Dementia , 2015, Alzheimer's & Dementia.
[114] Joanna M. Wardlaw,et al. Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability , 2016, NeuroImage.
[115] R. Carare,et al. The structure of the perivascular compartment in the old canine brain: a case study. , 2017, Clinical science.
[116] G. Wang,et al. Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations , 2015, Cellular and Molecular Neurobiology.
[117] A. Tricco,et al. Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.
[118] E. Stip,et al. Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB , 2007, European Psychiatry.
[119] C. Sudlow,et al. Differential gene expression in multiple neurological, inflammatory and connective tissue pathways in a spontaneous model of human small vessel stroke , 2014, Neuropathology and applied neurobiology.
[120] S. Mandal,et al. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease , 2011, Free radical research.
[121] D. Clair,et al. Bridging the translational divide: identical cognitive touchscreen testing in mice and humans carrying mutations in a disease-relevant homologous gene , 2015, Scientific Reports.
[122] Reinhard Schliebs,et al. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy , 2011, Acta Neuropathologica.
[123] I. Cuthill,et al. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research † , 2012, Osteoarthritis and Cartilage.
[124] B. Bell,et al. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. , 1985, Journal of neurosurgery.
[125] R. Carare,et al. Vascular basement membranes as pathways for the passage of fluid into and out of the brain Journal Item , 2018 .
[126] K. Smith,et al. Central demyelination induced in vivo by the calcium ionophore ionomycin. , 1994, Brain : a journal of neurology.
[127] I. Deary,et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities , 2014, Neurology.
[128] P. Heutink,et al. Mutations in Col4a1 Cause Perinatal Cerebral Hemorrhage and Porencephaly , 2005, Science.
[129] J. Crabbe,et al. Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.
[130] Kenneth J. Smith,et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide , 2005, Brain : a journal of neurology.
[131] W. Markesbery,et al. Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants , 2002, Annals of the New York Academy of Sciences.
[132] S. Pendlebury,et al. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.
[133] J. O'Brien,et al. Imaging of neuroinflammation in dementia: a review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[134] J. Wardlaw,et al. Early life risk factors for cerebrovascular disease , 2017, Neurology.
[135] A. Chalaris,et al. Mechanistic insights into a TIMP3-sensitive pathway constitutively engaged in the regulation of cerebral hemodynamics , 2016, eLife.
[136] T. Quinn,et al. Diagnosis in vascular dementia, applying 'Cochrane diagnosis rules' to 'dementia diagnostic tools'. , 2017, Clinical science.
[137] I. Deary,et al. Carotid disease at age 73 and cognitive change from age 70 to 76 years: A longitudinal cohort study , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[138] E. Hamel,et al. Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease , 2013, British journal of pharmacology.
[139] C. Lyketsos,et al. Treatment for mild cognitive impairment: systematic review , 2013, British Journal of Psychiatry.
[140] Maiken Nedergaard,et al. Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury , 2014, The Journal of Neuroscience.
[141] L. Wilkins. Gradual Carotid Artery Stenosis in Mice Closely Replicates Hypoperfusive Vascular Dementia in Humans , 2016, Journal of the American Heart Association.
[142] Per Kristian Eide,et al. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain , 2015, Acta radiologica open.
[143] Thomas Steckler,et al. Touching on translation , 2013, Cell and Tissue Research.
[144] Jess Nithianantharajah,et al. Cognitive components in mice and humans: Combining genetics and touchscreens for medical translation , 2013, Neurobiology of Learning and Memory.
[145] Joanna M. Wardlaw,et al. White matter hyperintensity reduction and outcomes after minor stroke , 2017, Neurology.
[146] C. Sobey,et al. Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. , 2012, Journal of applied physiology.
[147] P. Passmore,et al. Statins for the prevention of dementia. , 2016, The Cochrane database of systematic reviews.
[148] P. Scheltens,et al. Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment. , 2016, Stroke.
[149] Marc Fisher,et al. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.
[150] C. Iadecola,et al. Dangerous Leaks: Blood-Brain Barrier Woes in the Aging Hippocampus , 2015, Neuron.
[151] Berislav V. Zlokovic,et al. Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.
[152] L. Pantoni. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.
[153] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[154] P. Flecknell,et al. The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments) , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[155] Geoffrey A. Donnan,et al. Stroke Thrombolysis: Save a Minute, Save a Day , 2014, Stroke.
[156] Klaus P. Ebmeier,et al. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research , 2016, Alzheimer's & Dementia.
[157] N. Rothwell,et al. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[158] H. Chabriat,et al. Disruption of a miR‐29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathy , 2016, Annals of neurology.
[159] F. Faraci. Protecting against vascular disease in brain. , 2011, American journal of physiology. Heart and circulatory physiology.
[160] Maiken Nedergaard,et al. The Glymphatic System: A Beginner’s Guide , 2015, Neurochemical Research.
[161] Timothy J Bussey,et al. The touchscreen operant platform for testing learning and memory in rats and mice , 2013, Nature Protocols.
[162] A. Dominiczak,et al. Cerebral small vessel endothelial structural changes predate hypertension in stroke‐prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5‐ to 21‐week‐old rats , 2011, Neuropathology and applied neurobiology.
[163] Andrew E Moran,et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet. Global health.
[164] Peter Garrard,et al. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review , 2010, Journal of neurochemistry.
[165] C. Iadecola,et al. The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction , 2014, Nature Communications.
[166] A. van den Berg,et al. Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. , 2013, Lab on a chip.
[167] M. Macleod,et al. From a mouse: systematic analysis reveals limitations of experiments testing interventions in Alzheimer's disease mouse models , 2016, Evidence-based preclinical medicine.
[168] J. Bond,et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.
[169] Alan J. Thomas,et al. Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia , 2015, Brain : a journal of neurology.
[170] Jeffrey F. Thompson,et al. Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[171] Alexandra Naba,et al. Overview of the matrisome--an inventory of extracellular matrix constituents and functions. , 2012, Cold Spring Harbor perspectives in biology.
[172] A. D. de Craen,et al. High Blood Pressure, Physical and Cognitive Function, and Risk of Stroke in the Oldest Old: The Leiden 85-Plus Study , 2013, Stroke.
[173] Liping Liu,et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. , 2013, The New England journal of medicine.
[174] H. Stöhr,et al. Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice , 2016, Annals of neurology.
[175] M. Macleod,et al. Systematic Review and Meta-Analysis of Interventions Tested in Animal Models of Lacunar Stroke , 2014, Stroke.
[176] S. Tsuji,et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. , 2009, The New England journal of medicine.
[177] C. Iadecola,et al. Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1 , 2017, Proceedings of the National Academy of Sciences.
[178] J. C. de la Torre. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[179] M. Murphy,et al. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. , 2016, Biochimica et biophysica acta.
[180] B. Zlokovic,et al. Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[181] M. Trotter,et al. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility , 2012, Nature Biotechnology.
[182] Masafumi Ihara,et al. Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease , 2016 .
[183] D. Wilcock,et al. Vascular Contributions to Cognitive Impairment and Dementia: Topical Review of Animal Models. , 2016, Stroke.
[184] J. Cooke,et al. Overexpression of Dimethylarginine Dimethylaminohydrolase Protects Against Cerebral Vascular Effects of Hyperhomocysteinemia , 2010, Circulation research.
[185] Brianne A. Kent,et al. The touchscreen operant platform for assessing executive function in rats and mice , 2013, Nature Protocols.
[186] M. Prunotto,et al. Opportunities and challenges in phenotypic drug discovery: an industry perspective , 2017, Nature Reviews Drug Discovery.
[187] P. Sandercock,et al. Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.
[188] R. Kalaria. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease , 2016, Acta Neuropathologica.
[189] Dementia prevention: call to action , 2015, The Lancet.
[190] J. Wardlaw,et al. Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study , 2017, Trials.
[191] Francesca M Chappell,et al. Counting Cavitating Lacunes Underestimates the Burden of Lacunar Infarction , 2010, Stroke.
[192] C. Lourenço,et al. Neurovascular‐neuroenergetic coupling axis in the brain: master regulation by nitric oxide and consequences in aging and neurodegeneration , 2017, Free radical biology & medicine.
[193] Tian Feng,et al. The Effect of Body Posture on Brain Glymphatic Transport , 2015, The Journal of Neuroscience.